Poster Presentations Session #2

THURSDAY APRIL 30th , 2026
2:00-3:30 PM
PGRL Gallery


Poster # Presenter Title of study/project
     
11 Barbara Łasut-Szyszka Robust Activation of p53 as an Innovative Strategy to Enhance the Sensitivity of Cancer Cells to the FAS Receptor Ligand.
51 Noel Ong Exploring the Role of Microbiota in Cancer Development in Li-Fraumeni Syndrome.
52 Paula Quaglietta Metabolic reprogramming in Li-Fraumeni Syndrome underlies the pre-cancer niche and cancer predisposition.
60 Risha Banerjee p53 coordinates nucleotide metabolism and replication fidelity to enforce chromosomal stability.
59 Rentya Moses Variation at the R181 residue of p53 confers loss of p53 DNA binding cooperativity with the retention of mitochondrial-associated apoptosis.
61 Robert Schwarz Mechanisms of p53-mediated transcriptional regulation of transposable elements.
62 Ruiying Zhao Mutant p53 confers chemoresistance by activating KMT5B-mediated DNA repair pathway in nasopharyngeal carcinoma.
37 Lang Zou The role of p53 in early primary invasion.
75 Sabrina Weber MDM2 binds and suppresses RNA polymerase III to restrain the innate immune response to cytosolic DNA.
14 Büşra Yüksel Structure-Based Rational Design of a High-Affinity DARPin for Reactivating p53 Function.
24 Hailey Stack Early molecular signatures of TP53 loss of heterozygosity in Li-Fraumeni Syndrome.
63 Sasha Blay Harnessing Mutational Signatures to Pinpoint the Development of Chemoresistance in Metastatic and Relapsed Osteosarcoma.
64 Shunbin Xiong Elucidating the p53 transcriptome in the Pancreas for Novel PDAC Therapy.
7 Annabella Thomas Using fluorescent reporter mice and intravital imaging to investigate the p53 response to oncogene activation driving tumour development.
28 Jakov Vuk Structural and functional characterization of the p53–β-catenin interactome.
29 Juan Pablo Escorcia Domínguez Decoding Developmental Vulnerabilities in Sonic Hedgehog Medulloblastoma Tumorigenesis.
30 Julianne Funk Deep CRISPR mutagenesis characterizes the functional diversity of TP53 mutations.
67 Tanvi Anandampillai Exploring the prenatal genetic determinants of tumour risk in Li-Fraumeni syndrome: sequencing of newborn screening dried blood spots.
68 Tom Syme Design of Pharmacological Chaperones for Mutated p53.
69 Václav Brázda Promoter G‑Quadruplexes as Structure‑Encoded Switches of p53 Family Activity: Selective Enhancement of Partial‑Function Mutants.
85 Susan Kilgas A New Layer of p53 Control: The TIRR Pathway.
33 Käthe Lehnhoff DARPins for recognition and degradation of p53 mutants.
34 Katjana Schwab Unraveling mechanisms of RFX7 regulation.
36 Ksenia Magidey EXOp53 – An Extracellular Vesicle Based Platform for Functional p53 Replacement In Vivo.
38 Mackenzie Wienke Elucidating the mechanism of viral mimicry induction following p53 loss.
39 Madeleine Driscoll WNT Signaling Variants as Modifiers of TP53-Driven Cancer Susceptibility in Li-Fraumeni Syndrome.
70 Vincent Rondeau Targeted Prevention as a Novel Approach to Therapy-Related Myeloid Neoplasms.
71 Vinod Pant Examining the roles of Gtse1 and Eda2r as physiological effectors of p53 activity.
72 Wouter Jongeneel A mathematical perspective on the robustness of p53 oscillations.
73 YiQing Lü Functional Annotation of p53 Variants Using in vivo CRISPR Screening and Nurse-Led Clinical Translation.
74 Zdenek Andrysik Translatome and Proteome Dynamics Modulate the p53 Network.
77 Jung-Won Lee RUNX3-p53-MYC interplay determines metastatic outgrowth in gastric cancer.
78 Meg Dillingham McCullough Quantitative single-cell analysis of p53 restoration in TP53-null ovarian cancer cells.
79 Airlia Shaffer Regulation of p53’s Dual Roles in DNA Repair and Transcription by Time-Dependent Modifications.
80 David Miller The Origin and Consequences of Heterogeneous p53 Dynamics in Single Cells.
81 Sylvain Peuget Enterobacteria induce colorectal cancer chemoresistance through stromal-mediated repression of p53.
82 Hayla Sluss p53 ser 18 regulates post- prandial glucose homeostasis.
83 Mahsa Farjami Identification of Immunogenic Tumor Antigens for an mRNA-LNP Interception Cancer Vaccine in Li-Fraumeni Syndrome.
87 Christopher Cowley Identification of inflammation induced epigenetic drivers of colitis-associated colorectal cancer.
88 Shuai Allan Huang Targeting pro-survival proteins to modulate cell fate following p53 activation.

👉 POSTER SESSION #1
WEDNESDAY APRIL 29th , 2026
2:00 – 3:30

 

/ program / poster-session-2